LETTER FROM THE MEDICAL DIRECTORFew people live a full lifespan without seeing an oph-thalmologist. According to the American Academy of Ophthalmology (AAO), in the US alone, six out of every ten adults need some type of corrective eye-wear. Thankfully for most of the population, a good pair of glasses or contact lenses, or a Laser vision procedure corrects the shape of the cornea or loss of flexibility in the lens that causes the loss of vision. For many people, the threats to visual health are more severe. Our comprehensive diagnostic and treatment protocols to assist such patients are all evidence based with significantly higher success rates than the industry standards. For instance, our SupraLASIK re-treatment rates are as low as 0.05% as compared to industry norms of up to 20% for reg-ular LASIK procedures - this really sets us apart and has led to word of mouth referrals coming for treat-ment from all corners of the world.

Undoubtedly, the success of a medical establishment is measured usually by the number of satisfied pa-tients who praise the treatment and services offered by the organization. For us, it is the feedback and sup-port of thousands of happy patients we have treated in the last 30 years in the Middle East that keeps us on our toes to constantly innovate and remain at the forefront of what we do.

In response to such patient feedback and the demand for uncompromised high quality eye care, we have commenced the process of growing our services to beyond our flagship facility in Dubai. We are now also operational in Khalifa City A, Abu Dhabi. In the upcom-ing future we shall have two Centers operational in 2018 in Africa, and another 3 centers to be in opera-tion in 2019 in GCC.

We believe, with the "dare to be first" philosophy, as well as through our quality-focused approach and relentless pursuit of perfection, Imperial Healthcare Institute will continue to provide the impetus for a completely new paradigm in the eye-care industry not only in the Middle East, but globally.

PROFESSOR DR. VINOD GAUBAFRCOPHTH (UK), PAMED (UK), MBBS (HONS, UK)

Quarterly Newsletter for the Patients & Friends of Imperial Healthcare Institute

Issue 10 / 01 - Jan 2018

Eye Care News

Imperial Healthcare Institute welcomes on Board Dr Main Farraj, who Acquired his medical qualifications from UK and Romania and held many positions in many hospitals in UK including Queen Victoria Hospital Nhs ,East Grinstead UK. Dr. Farraj is an ophthalmic eye surgeon with big intrest in Anterior segment surgery ,dry eyes , Blepharitis keratoconus ,cataract and diabetic retinopathy .He Took part in different researches in Romania and UK studying the relation between the increase of oxidative stress and free radicals and the effects on human body tissues. Dr.Faraj speaks fluently Arabic, English ,and Romanian.

Imperial Healthcare Institutes will be celebrating shortly the 10 years of operation at Dubai Healthcare City. If you wish to be part of these celebrations, register your quote at our Facebook page , and you could win free consulta-tions and procedures.

We speak your language at Imperial Healthcare Institute. With over 15 languages spoken by our team, we are ready to welcome you at Imperial Health Institute. If we do not communicate with you in your language, you may request an extra special discount for any SupraLift or Supralasik procedures.

Imperial Healthcare Institute is meeting you in Abu Dhabi.We are happy to meet all our patients and Friends in Abu Dhabi.Call us Now @ 800 800 Eye (393) to book the appointment with our Consultants.

Imperial Healthcare Institute Dubai Healthcare City Re-ceives "Best Ophthalmology Service Provider of the Year “at the Global Health Re-wards 2017

ANNOUNCEMENT AND WELCOMING DR MAIN FARRAJ

OUR 10th ANNIVERSARY

NEWS

LANGUAGE CHALLENGEAT IMPERIAL HEALTHCARE INSTETUTE

IMPERIAL HEALTHCARE SERVICES IN ABU DHABI

A BEFORE TREATMENT , B,C & D AFTER TREATMENT

The peripheral part of the retina is divided into four quadrants where is the severi-ty of the disease depends on how many quadrants are involved and at what level.

At early stage of the disease the blood vessels show a slight change of calliper and microscopic haemorrhages into the retina can be seen.

ADVANCED DIABETIC RETINOPATHY Untreated eyes can end up with Retinal detachment and complete vision loss which is in some cases can be permanent.Earlier stages of Diabetic Retinopathy can be treated with Laser photocoagulation with or without intra ocular medication like steroids or antigrowth fibrovascual agents such as Lucentis.

Surgical treatment can be a sight saving where conventional methods have failed to stop the progression of disease.

Most Retinal eye surgery nowadays can be done under local anaesthesia and no hospitalization is required.

Having a systematic method of screening, proper referral and follow up of Diabetic patients by the specialists will hugely re-duce the incidence of vision loss caused by diabetes, maintain the quality of life and lower the financial impact on individ-uals and governments.

EARLY DIABETIC EYE DISEASEModerate stage can be more severe with almost all quadrants involved and in-creased tortuosity of the blood vessels. At advance stage abnormal blood vessels can start to develop at the optic disc or elsewhere, if not treated can start to bleed into the eye cavity causing significant loss of vision.

Diabetes Mellitus is one of the most chal-lenging medical conditions affecting many people worldwide especially in our region. According to the recent report the Gulf Re-gion has almost the highest incidence of Diabetes comparing to other regions which is almost affecting 25% of the adult popu-lation.

One of the major side effects with Diabetes is the ocular involvement in the form of Dia-betic Retinopathy.

Less problematic with Diabetes is the early development of Cataract comparing to nor-mal individuals which is usually successful-ly treated with no adverse events.

NORMAL EYE FUNDUS

Regular eye test and screening by a special-ized eye doctor is very important to detect early stages of the disease which will pre-vent permanent vision loss if treated early.Poorly controlled Diabetic patients are at higher risk of developing Diabetic Retinop-athy and can be slower to respond to treat-ment.

Diabetic Retinopathy occurs when the Reti-na blood vessels start to leak and swell up which can lead to loss of vision.

There are different levels of Diabetic Retin-opathy according to extent of disease and areas involved.

Normally the Central part of the Retina that is called the Macula, which is the most sensitive part of the vision, appears dark-er than the rest of the retina and it has no blood vessels running across.

The major effect on the central part of the Retina is usually with the leakage of fluids which can blur the central part of vision. This usually leads to increase thickness of this part of the retina which is now days can be measured with special equipment that is very useful in terms of diagnosis and mon-itoring recovery during the course of man-agement.

DIABETES AND YOUR EYES: PREVENTION FIRST

BY DR. QASIM QASEMFRCS, MRCSI, FEBO,

CALLING FROM UAE

FOR OUR SERVICES IN

DUBAI & ABU DHABI 800 800 EYE(393)

SupraLIFT™ SOFT SURGERY (THE INSTANT LIFT)

WHAT IS SupraLIFT™ ?

SupraLIFT™ a noninvasive procedure to achieve the same results of the bleph-aroplasty surgery and perfect for men and women.

The SupraLIFT™ uses plasma laser tech-nology that has given an alternative to the traditional Blepharoplasty surgery that removes sagging eyelids, brow lift, and take decades off your eyelids. With-out the inherited risks of the gold stand-ard blepharoplasty surgery.

WHY SupraLIFTTM ?• Saggy / excess upper eyelid skin• Baggy lower eyelid skin• Skin lesions, warts, xanthelasma• Lines and wrinkles (smokers lines)• Crows feet• Skin Tags• Sun Spots or Age Spots• Ache Scars• Tattoos

INTRAVITREALINJECTIONS

WHAT IS IT?WHAT EXACTLY IS ANINTRAVITREAL INJECTION (INJECTION)?

This is a minor surgery, which involves the injection into the eye (vitreous) of a sub-stance as the underlying condition may be either cortisone or a new class of drugs, the anti-angiogenic drugs.The injections are given by specialist in diseases of the retina and macular oph-thalmologists in specially designed areas. In their application, strict rules of sterility are followed and specially designed tools are used, that make the whole process very fast (takes about 6 minutes) and painless.

WHAT ARE THE SIGNS AND HOW DO INTRAVITREAL IN-JECTIONS WORK?

Diseases such as Age related macular de-generation (AMD), diabetic retinopathy (DR) and, to a lesser extent, other vascular and inflammatory eye diseases are the most frequent indication for the application of in-travitreal injections.These patients have lesions in the blood vessels that supply nutrients to the eye. Often weak and abnormal vessels also grow, that tend to bleed and leak fluid in the macular region. With intravitreal injections of appropriate drugs, inhibition of growth of abnormal blood vessels is caused and bleeding and leakage are reduced.

WHAT ARE THE RESULTS OF TREATMENT WITH INTRA-VITREAL INJECTIONS?

Traditional forms of treatment such as la-ser aim at the stabilization and not at the improving of the vision. This means that, in patients where some of the current treat-ments were successfully implemented, the vision, at best, remains stable or deterio-rates rapidly.With the intravitreal injections of new drugs, improvement of the vision is obtained in about half of the patients while further de-terioration of vision is prevented at a rate exceeding 90%. These results depend on the size and the age of the original lesion, and in many cases, repeated injections are required to maintain a successful result.

WHEN TO REFER TO IMPERIAL HEALTH-CARE INSTITUTE

ALL REFERRALS FROM OTHER CLINICS OR HOSPI-TALS ARE TREATED ON TOP PRIORITY BASIS.

Completing its 9 years at Dubai Health-care City, Imperial Healthcare Institute proud the Quality Service towards pa-tients and The Trust Factor From our Referrals and Colleagues.

Our Group of Ophthalmologists will be ready to assist in all the following:

1. ANY ACUTE ONSET PAINFUL OR PAINLESS LOSS OF VISION,

2. BINOCULAR DOUBLE VISION,

3. EYELID /PERI ORBITAL ABNOR-MALIT IES,

4. RED EYE WITH VISUAL LOSS

5. MAJOR EYE TRAUMA

6. ANY SIGHT SYMPTOMS OF KIDS

7. EYE COMPLICATIONS RELATED TO DIABETES

IMPERIAL HEALTHCARE INSTITUTE

Center for Sight |SupraLASIK™ | The Eyelid Clinic Skin Rejuvenation

101, Block A, Ibn Sina

Building 27, DHCC

Toll Free

800 800 EYE(393) +971 4 439 3737 +971 4 439 3736

info@imperialhealth.org

www.imperialhealth.org

Imperial Healthcare Institute

OphthalmologyServices Provider

of the YearGlobal Health

Awards2017

BestEye Care Clinic

of the Year Asian Awards

2015

TM

www.supra-lift.com

GET RID OF EYE BAGSTREAT DROOPY HEAVY EYELIDS

FOR YOUR

CONSULTATION

www.supralasik.com

SURGERYW THOUT

Donein LessThan

PLEASE VISIT US ON THE FIRST FLOOR

OR CALL 04 439 3737FOR MORE INFORMATION

OtherServices

Advanced Cataract SurgeryKeratoconus TreatmentDiabetic Eye Disease

HD Vision with ICL ImplantsTrifocal / Multifocal LensesBlephexTM Lid Exfoliation

Artifical EyeStrabismus ManagementSkin Laser Rejuvenation

Botulinum Toxin, Fillers Acupuncture

Tearduct and Orbital Surgery

ASIK™ the unique non-surgical solution to vision correction and the SuperLIFT, the noninvasive procedure to achieve the same results of the blepharoplasty surgery.

About Imperial Healthcare Institute:

Imperial Healthcare Institute is a re-gional hub for specialized eye care in Dubai Healthcare City. It is dedicated to providing excellence in clinical care by adhering to the highest International clinical standards and delivering world class expertise in an integrated mul-ti- specialty environment. The facility provides day care surgery, outpatient diagnostics and treatments for a va-riety of surgical and non-surgical eye conditions from eyelid rejuvenation through to complex trauma and sight threatening diseases.

The organization has its foundations in the United Arab Emirates since 1978 with the latest facility in Dubai Health-care City inaugurated in 2008. A new operation has been launched in Abu Dhabi earlier in 2017. Two more centers are to be opened in Africa by end of this year.

IMPERIAL HEALTHCARE INSTITUTE DUBAI HEALTHCARE CITY RECEIVES "BEST OPHTHALMOLOGY SERVICE PROVIDER OF THE YEAR “AT THE GLOBAL HEALTH REWARDS 2017:

Dubai, United Arab Emirates: Imperi-al Healthcare Institute, a Dubai Health Care City -based hospital known of ex-cellence in eye care, is announced the winner of the Global Health awards 2017 as “Ophthalmology Service Pro-vider of the year”.

The award was received by Prof. Dr Vinod Gauba, The Founder and the Medical Director. Commenting on the accolade, Prof. Dr Gauba said, “We are Thrilled and honored to receive anoth-er International Reward. We have been in the region for 40 years. As a center of Excellence in Ophthalmology, we are having the privilege of represent-ing Dubai and the Middle East in these rewards. This reward is a testament to our diligent, ethical and uncompro-mised approach to providing the high-est standard of eye care available. Furthermore, this reward is important step for the Asian Market to start rec-ognizing Dubai as an upcoming player in the Medical Tourism Field”.

Prof Dr. Gauba added “We believe at Imperial Healthcare Institute , with the "dare to be first" philosophy, as well as through our quality-focused attitude and dual persistence, Imperial Health-care Institute will provide the impetus for a completely new paradigm in the Health-care industry not only in the Middle East but globally, likewise”.

Imperial Healthcare is recognized for its comprehensive Ophthalmology Treatment protocol along with some pioneering techniques such as SupraL-